Bicocca Open Archive

Logo unimib boa
QUARTI TREVANO, FOSCA ANNA LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.276
AS - Asia 11.668
EU - Europa 7.539
SA - Sud America 1.704
AF - Africa 289
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 11
Totale 38.509
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.312
SG - Singapore 3.863
CN - Cina 2.372
VN - Vietnam 2.163
HK - Hong Kong 1.473
IT - Italia 1.448
RU - Federazione Russa 1.335
BR - Brasile 1.294
DE - Germania 1.164
SE - Svezia 952
CA - Canada 819
IE - Irlanda 675
UA - Ucraina 464
GB - Regno Unito 391
FR - Francia 334
IN - India 329
BD - Bangladesh 318
KR - Corea 242
FI - Finlandia 202
AR - Argentina 148
IQ - Iraq 135
AT - Austria 134
ID - Indonesia 126
TR - Turchia 107
ZA - Sudafrica 97
MX - Messico 81
PK - Pakistan 80
JP - Giappone 75
NL - Olanda 70
ES - Italia 66
PL - Polonia 66
SA - Arabia Saudita 64
PH - Filippine 60
CO - Colombia 57
EC - Ecuador 56
VE - Venezuela 56
DK - Danimarca 43
UZ - Uzbekistan 43
KE - Kenya 32
MY - Malesia 31
EG - Egitto 27
BE - Belgio 25
CZ - Repubblica Ceca 25
TN - Tunisia 25
MA - Marocco 24
PY - Paraguay 24
CL - Cile 23
ET - Etiopia 23
AU - Australia 22
JO - Giordania 20
LT - Lituania 20
NP - Nepal 18
AE - Emirati Arabi Uniti 16
PE - Perù 16
DZ - Algeria 15
AL - Albania 13
AZ - Azerbaigian 13
BO - Bolivia 13
CH - Svizzera 13
RO - Romania 13
UY - Uruguay 13
IR - Iran 12
EE - Estonia 11
JM - Giamaica 11
LB - Libano 11
BG - Bulgaria 10
BY - Bielorussia 10
HN - Honduras 10
KZ - Kazakistan 10
TW - Taiwan 10
HU - Ungheria 9
LK - Sri Lanka 9
MK - Macedonia 9
CR - Costa Rica 8
PS - Palestinian Territory 8
PT - Portogallo 8
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 7
IL - Israele 7
PA - Panama 7
SN - Senegal 7
GE - Georgia 6
KW - Kuwait 6
NG - Nigeria 6
OM - Oman 6
XK - ???statistics.table.value.countryCode.XK??? 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
KG - Kirghizistan 5
NI - Nicaragua 5
RS - Serbia 5
TH - Thailandia 5
EU - Europa 4
MU - Mauritius 4
NO - Norvegia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
AM - Armenia 3
AO - Angola 3
GR - Grecia 3
Totale 38.448
Salva come PNG Salva come JPEG
Città #
Singapore 2.228
Ann Arbor 2.182
Ashburn 1.612
Hong Kong 1.447
San Jose 1.138
Fairfield 986
Woodbridge 936
Houston 712
Frankfurt am Main 706
Ho Chi Minh City 650
Dublin 637
Toronto 632
Chandler 573
Dallas 529
Hanoi 520
Wilmington 515
Jacksonville 471
Hefei 467
New York 407
Seattle 372
Beijing 357
Milan 342
Chicago 324
Dearborn 318
Cambridge 307
Santa Clara 299
Los Angeles 296
Princeton 246
Seoul 232
The Dalles 216
Boardman 193
Lauterbourg 156
Moscow 150
Shanghai 124
Lawrence 121
Altamura 120
São Paulo 115
Nanjing 114
Vienna 110
Buffalo 104
Da Nang 96
Munich 89
Council Bluffs 88
Orem 84
Helsinki 77
Haiphong 75
Lachine 73
Rome 72
Jakarta 71
San Diego 69
Guangzhou 66
Atlanta 56
Baghdad 55
London 55
Chennai 53
Lissone 50
Rio de Janeiro 49
Tokyo 49
Warsaw 48
Dong Ket 44
Andover 42
Brooklyn 42
Hangzhou 42
Nuremberg 42
Denver 40
Quận Bình Thạnh 40
Nanchang 38
Tashkent 38
Johannesburg 37
Changsha 36
Ha Long 36
Montreal 36
Tianjin 36
Turku 36
Salt Lake City 33
Can Tho 31
Dhaka 31
Düsseldorf 31
Hebei 31
Hải Dương 31
Phoenix 29
San Francisco 29
Zhengzhou 28
Mumbai 27
Ninh Bình 27
Vũng Tàu 27
Biên Hòa 26
Fremont 25
Thái Nguyên 25
Belo Horizonte 24
Falls Church 24
Jiaxing 24
Kent 24
Brasília 23
Columbus 23
Lahore 23
Brussels 22
Jinan 22
Monza 22
Nairobi 22
Totale 24.508
Salva come PNG Salva come JPEG
Nome #
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 485
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes 459
Contrasting effects of carotid baroreceptor stimulation on regional sympathetic drive in chronic human heart failure 446
Heart rate as a sympathetic marker during acute adrenergic challenge 433
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 419
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 346
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 333
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 332
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 323
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 320
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms 312
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 308
Neurogenic abnormalities in masked hypertension 304
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 298
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 293
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 292
Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: Results of a double-blind randomized multicentre trial 290
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 289
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 286
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 282
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 281
Threshold and Target for Blood Pressure Lowering in the Elderly 275
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives 273
Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan 273
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease 272
Heart Rate, Sympathetic Cardiovascular Influences, and The Metabolic Syndrome 272
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 271
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 270
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 270
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 269
Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives 265
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 265
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 265
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 264
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 263
Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique 261
Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes 260
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 259
Iron overload exerts sympathoexcitatory effects in men with essential hypertension: microneurogtaphic evidence 256
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 256
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 250
Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension 249
Effects of hypertension and obesity on the sympathetic activation of heart failure patients 248
Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction 246
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 246
Behaviour of regional sympathetic nerve traffic in obstructive sleep apnea syndrome 243
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity 242
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome 242
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 242
Diurnal blood pressure variation and sympathetic activity 242
Hypertension, antihypertensive treatment and stroke prevention 239
Should white-coat hypertension in diabetes be treated? Pro 239
Adrenergic and metabolic effects of bariatric surgey in obese subjects: a longitudinal study 239
SYMPATHETIC OVERDRIVE IN THE RESISTANT HYPERTENSIVE PHENOTYPE 238
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 237
Incident Left Ventricular Hypertrophy in Masked Hypertension 236
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 234
Effects of acute carotid baroreceptor stimulation on sympathetic nerve traffic in resistant and uncontrolled hypertension: a systematic review and meta-analysis 233
Early sympathetic activation in the initial clinical stages of chronic renal failure 233
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 233
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 233
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 232
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project) 231
Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension 230
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 225
Sympathetic activation in congestive heart failure: an updated overview 223
Long-term risk of sustained hypertension in white-coat or masked hypertension 222
Early sympathetic activation in mild renal failure 221
New onset left atrial dilatation in the general population: A quarter-century follow-up 220
Blood pressure lowering effects of Rimonabant in obesità-related hypertension 220
Baroreflex function in hypertension: consequences for antihypertensive therapy 220
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 220
Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials 216
HYT-Hypertension in Turkey: A Cross-Sectional Survey on Blood Pressure Control with Calcium Channel Blockers Alone or Combined with Other Antihypertensive Drugs 215
Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings 215
Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension 214
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 213
Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity 213
Association Between Arterial Stiffness, High Blood Pressure, and Hypertensive Phenotypes: Insights from the PAMELA Study 212
The "J curve" problem revisited: old and new findings 212
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 211
Left ventricular mass reduction and hypertrophy regression following renal artery revascularization: a meta-analysis 208
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 206
Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns 206
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 206
Blood pressure control in resistant hypertension: new therapeutic options 205
Left ventricular hypertrophy in isolated and dual masked hypertension 203
Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients 203
Association between ADRA1A gene and the metabolic syndrome: Candidate genes and functional counterpart in the PAMELA population 202
Habitual coffee consumption and office, home, and ambulatory blood pressure: results of a 10-year prospective study 201
Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea 201
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 200
Salt intake and sympathetic activity - Response 198
Habitual Regular Coffee Consumption And Arterial Stiffness -Data From The 3rd Pamela Survey 197
Sympathetic activation in congestive heart failure: Evidence, consequences and therapeutic implications 196
Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies 196
Response to sympathetic activity, heart failure, obesity, and metabolic syndrome: Is there any role for obstructive sleep apnea? 195
The 'neuroadrenergic hypothesis' in hypertension: current evidence 194
Diagnostic and Therapeutic Approach to Different Hypertensive Phenotypes According to the 2023 ESH Guidelines 193
Essential hypertension and the sympathetic nervous system 191
Totale 25.420
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.805
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021248 0 0 0 0 0 0 0 0 0 0 0 248
2021/20222.063 165 171 263 201 177 162 110 83 110 128 195 298
2022/20232.814 320 813 274 271 165 453 48 157 159 20 89 45
2023/20242.231 56 56 112 120 298 501 387 74 252 67 51 257
2024/20256.380 321 721 250 268 518 185 299 278 607 979 723 1.231
2025/202616.887 2.287 1.440 1.433 1.748 1.576 825 2.174 752 1.243 1.461 1.176 772
Totale 39.159